Published in Cancer Weekly, May 10th, 1999
In previous research, M. Kikuchi and colleagues from Kurume University School of Medicine, Japan, described the SART-1 gene-encoding peptides recognized by HLA-A2601-restricted and tumor-specific cytotoxic T lymphocytes (CTLs).
In their current research, they investigated whether SART-1 encodes peptides capable of inducing the HLA-A24-restricted CTLs ("Identification of a SART-1-Derived Peptide Capable of Inducing HLA-A24-Restricted and Tumor-Specific Cytotoxic T Lymphocytes," International Journal of Cancer, May 5, 1999;81(3):459-466).
"Among the 18...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.